Silver nanoparticles produced by the fungus Trichoderma reesei could become important allies in the prevention and treatment ...

Loneliness speeds up aging, new research finds—and even short-term feelings matter. Fortunately, daily connection can protect ...

A study published April 12 in Nature Communications identifies a protein that helps prevent excessive scarring. The protein, ...

As India battles rising asthma cases driven by pollution and lifestyle shifts, innovations in diagnosis, inhalers, and ...

PDS Biotechnology Corporation’s PDSB share price has dipped by 5.76%, which has investors questioning if this is right time ...

In April 2025, Novartis Pharmaceuticals announced study is to establish the efficacy, safety, and tolerability of ...

Guselkumab significantly improves clinical remission rates in patients with active ulcerative colitis, according to phase 3 data.

New long-term extension data from the Phase IIb/III QUASAR trial demonstrate that Tremfya (guselkumab) maintains durable ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

A shared neuroimmune pathway involving CRH, mast cells, and Th17 cells may underlie the link between psoriatic arthritis and ...